Digital
18th - 19th November 2021

6th Annual MarketsandMarkets High Potent Medicines Virtual Conference (TIME ZONE- CET)

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.

users

The 2-day event will share the latest industry trends, advancements and future growth in the highly potent medicines market where leading industry experts will discuss the strategies for both pharma and CMO’s by presenting expert keynote presentations, live case studies and breakthrough panel sessions.

users

Discussing strategies for effective management of high potent medicines supply chain, sessions on how to do a competent toxicological evaluation of HPAPI and Overview of the new ASTM E3106 Cleaning Standard

users

Expert keynote presentations, live case studies, and breakthrough panel sessions on Solutions to the challenges with regards to cleaning and validation in API Manufacturing and procedures to avoid cross-contamination.

The 6th Annual MarketsandMarkets High Potent Medicines Virtual Conference to be held on 11-12 November 2021. This conference would address the challenges in continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.

WHAT TO EXPECT
Key Highlights
  • Process Development and scale up of HPAPI’s
  • Strategies for effective outsourcing partnership
  • Containment and Handling Strategies
  • Validation of cleaning procedures to avoid cross contamination
  • Regulatory Landscape
  • Hazard Assessment Classifications
Who Should Attend?

From pharmaceutical and Biopharmaceutical manufacturing:

Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in:

  • Research & Development
  • Manufacturing/Operations/Production
  • Maintenance
  • Engineering
  • Risk Assessments
  • Laboratory Services/Analytical
  • New Technologies
  • Process Development/Technical transfer
Why Attend?
  • Utilizing the best practices to ensure safe and efficient production of high potent medicines
  • Training sessions on complex high potent compounds handling and containment issues
  • Understanding the updated regulatory guidelines in the HPAPI process
  • Implementing response plans to react to an unplanned event
  • Knowing the outsourcing strategies to effectively build a reliable supply chain
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Fabio Zenobi

Fabio Zenobi

EHS Director
BSP Pharmaceuticals, Italy

Fabio Zenobi

EHS Director
BSP Pharmaceuticals, Italy
Stefano Butti

Stefano Butti

Sales Director
Food Pharma Systems, Italy

Stefano Butti

Sales Director
Food Pharma Systems, Italy
Ester Lovsin Barle

Ester Lovsin Barle

Head, Product Stewardship and Health
Takeda, Switzerland

Ester Lovsin Barle

Head, Product Stewardship and Health
Takeda, Switzerland
Dean Calhoun

Dean Calhoun

President, CEO
Affygility Soultions, USA

Dean Calhoun

President, CEO
Affygility Soultions, USA
Martin Kohan

Martin Kohan

Senior Occupational Toxicologist
AstraZeneca, UK

Martin Kohan

Senior Occupational Toxicologist
AstraZeneca, UK
Ildiko Ziegler

Ildiko Ziegler

Quality Assurance Manager
Vanessa Research

Ildiko Ziegler

Quality Assurance Manager
Vanessa Research
Andrew Lemaire

Andrew Lemaire

Technical Director, Containment and Micronisation
Dietrich Engineering Consultants, Switzerland

Andrew Lemaire

Technical Director, Containment and Micronisation
Dietrich Engineering Consultants, Switzerland
Jack Brown

Jack Brown

Consultant
Scale Up Solutions, USA

Jack Brown

Consultant
Scale Up Solutions, USA
SPONSORS
Leading Partner
example-image

FPS

Speaking Partner
example-image

BSP Pharmaceuticals

example-image

Dec Group

PAST EVENT GALLERY